News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,410 Results
Type
Article (43474)
Company Profile (250)
Press Release (672685)
Multimedia
Podcasts (67)
Webinars (14)
Section
Business (205696)
Career Advice (2083)
Deals (35640)
Drug Delivery (103)
Drug Development (82533)
Employer Resources (174)
FDA (16403)
Job Trends (15073)
News (348903)
Policy (33135)
Tag
Academia (2644)
Accelerated approval (10)
Adcomms (23)
Allergies (96)
Alliances (49909)
ALS (110)
Alzheimer's disease (1452)
Antibody-drug conjugate (ADC) (156)
Approvals (16396)
Artificial intelligence (313)
Autoimmune disease (29)
Automation (19)
Bankruptcy (363)
Best Places to Work (11772)
BIOSECURE Act (19)
Biosimilars (122)
Biotechnology (175)
Bladder cancer (94)
Brain cancer (37)
Breast cancer (368)
Cancer (2904)
Cardiovascular disease (217)
Career advice (1746)
Career pathing (30)
CAR-T (190)
CDC (36)
Cell therapy (511)
Cervical cancer (23)
Clinical research (67882)
Collaboration (1018)
Company closure (3)
Compensation (686)
Complete response letters (25)
COVID-19 (2673)
CRISPR (58)
C-suite (332)
Cystic fibrosis (113)
Data (3023)
Decentralized trials (2)
Denatured (20)
Depression (63)
Diabetes (354)
Diagnostics (6492)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (139)
Drug pricing (132)
Drug shortages (29)
Duchenne muscular dystrophy (127)
Earnings (87636)
Editorial (42)
Employer branding (22)
Employer resources (150)
Events (115742)
Executive appointments (850)
FDA (18064)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (940)
Gene editing (133)
Generative AI (22)
Gene therapy (384)
GLP-1 (809)
Government (4615)
Grass and pollen (4)
Guidances (181)
Healthcare (19220)
HIV (40)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (151)
Immuno-oncology (10)
Indications (39)
Infectious disease (2848)
Inflammatory bowel disease (152)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (121)
Interviews (321)
IPO (16672)
IRA (44)
Job creations (3688)
Job search strategy (1483)
Kidney cancer (13)
Labor market (52)
Layoffs (498)
Leadership (18)
Legal (8052)
Liver cancer (79)
Longevity (11)
Lung cancer (406)
Lymphoma (209)
Machine learning (11)
Management (59)
Manufacturing (389)
MASH (90)
Medical device (13554)
Medtech (13559)
Mergers & acquisitions (19692)
Metabolic disorders (869)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (115)
Neuropsychiatric disorders (32)
Neuroscience (2139)
NextGen: Class of 2025 (6658)
Non-profit (4664)
Now hiring (47)
Obesity (439)
Opinion (226)
Ovarian cancer (101)
Pain (108)
Pancreatic cancer (120)
Parkinson's disease (189)
Partnered (22)
Patents (299)
Patient recruitment (168)
Peanut (50)
People (58365)
Pharmaceutical (63)
Pharmacy benefit managers (23)
Phase I (21117)
Phase II (29854)
Phase III (22252)
Pipeline (1644)
Policy (209)
Postmarket research (2697)
Preclinical (9075)
Press Release (65)
Prostate cancer (142)
Psychedelics (37)
Radiopharmaceuticals (258)
Rare diseases (465)
Real estate (5987)
Recruiting (66)
Regulatory (22954)
Reports (50)
Research institute (2377)
Resumes & cover letters (354)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (159)
Series B (109)
Service/supplier (11)
Sickle cell disease (63)
Special edition (19)
Spinal muscular atrophy (150)
Sponsored (32)
Startups (3614)
State (2)
Stomach cancer (15)
Supply chain (76)
Tariffs (59)
The Weekly (45)
Vaccines (794)
Venture capital (54)
Weight loss (267)
Women's health (47)
Worklife (17)
Date
Today (92)
Last 7 days (354)
Last 30 days (1842)
Last 365 days (31424)
2025 (16931)
2024 (35484)
2023 (40364)
2022 (51490)
2021 (56026)
2020 (54584)
2019 (47260)
2018 (35570)
2017 (32482)
2016 (32010)
2015 (38089)
2014 (31883)
2013 (27007)
2012 (29252)
2011 (29918)
2010 (28248)
Location
Africa (747)
Alabama (61)
Alaska (7)
Arizona (245)
Arkansas (13)
Asia (38790)
Australia (6389)
California (7456)
Canada (2364)
China (681)
Colorado (321)
Connecticut (318)
Delaware (192)
Europe (83770)
Florida (1121)
Georgia (250)
Hawaii (1)
Idaho (59)
Illinois (646)
India (27)
Indiana (362)
Iowa (17)
Japan (229)
Kansas (110)
Kentucky (30)
Louisiana (14)
Maine (64)
Maryland (1032)
Massachusetts (5584)
Michigan (248)
Minnesota (452)
Mississippi (3)
Missouri (91)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (68)
New Jersey (2094)
New Mexico (29)
New York (2093)
North Carolina (1090)
North Dakota (9)
Northern California (3283)
Ohio (236)
Oklahoma (16)
Oregon (34)
Pennsylvania (1616)
Puerto Rico (17)
Rhode Island (37)
South America (1145)
South Carolina (34)
South Dakota (1)
Southern California (2791)
Tennessee (127)
Texas (1129)
United States (27729)
Utah (221)
Virginia (186)
Washington D.C. (73)
Washington State (636)
West Virginia (4)
Wisconsin (68)
716,410 Results for "american regent inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Izotropic Revises License Agreement with The Regents of the University of California
June 10, 2025
·
4 min read
Press Releases
Endogenex Highlights 48-Week REGENT-1 Clinical Study Results at Digestive Disease Week 2025
May 5, 2025
·
3 min read
Press Releases
American Regent introduces FDA-approved Epinephrine Injection, USP in 30 mL
October 29, 2024
·
8 min read
Press Releases
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
July 9, 2025
·
3 min read
Policy
American Regent Introduces Potassium Phosphates, USP; FDA-Approved and “AP” Rated¹
American Regent announces the launch and availability of Potassium Phosphates Injection, USP, which is FDA-approved and therapeutically equivalent to Potassium Phosphates.1 Potassium Phosphates Injection, USP is indicated as a source of phosphorus:
October 19, 2023
·
9 min read
Pharm Country
American Regent Introduces Levocarnitine Injection, USP; FDA-Approved, AP Rated, and Therapeutically Equivalent to Carnitor®¹
American Regent announces the release and availability of Levocarnitine Injection, USP, FDA-approved, “AP” rated, and therapeutically equivalent to Carnitor®.
October 10, 2023
·
6 min read
Drug Development
American Regent Announces Results From Phase 3 HEART-FID Trial with INJECTAFER®
American Regent, Inc., a Daiichi Sankyo Group company, announced results from the phase 3 HEART-FID trial of INJECTAFER® for the treatment of iron deficiency in adult heart failure patients with reduced ejection fraction.
August 26, 2023
·
12 min read
Pharm Country
American Regent introduces FDA-approved Epinephrine Injection, USP
American Regent announces the launch of sulfite-free Epinephrine Injection, USP.
March 30, 2023
·
7 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Acceptance of Abstracts at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
May 29, 2025
·
2 min read
Press Releases
Endogenex to Present Data on Endoscopic Procedure for Type 2 Diabetes at American Diabetes Association’s (ADA) 85th Scientific Sessions
June 17, 2025
·
2 min read
1 of 71,641
Next
